CNRVX Performance — City National Rochdale U.s. Core Equity Fund, Servicing Class
Data updated: 2025-11-28
CNRVX returned +13.92% over one year to Sep 2025. Annualised returns are +21.92% over 3 years and +13.45% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $181, against $170 for the category, and to $114 over one year, against $113. Volatility over the past three years was 12.82% a year. In the 12 months to Sep 2025 the fund lost a net $15.8M, and assets reached $381.91M.
CNRVX Growth of $100
What $100 invested in City National Rochdale U.s. Core Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | CNRVX | Category average |
|---|---|---|
| 1 year (Oct 2024 – Sep 2025) | $114 | $113 |
| 3 years (Oct 2022 – Sep 2025) | $181 | $170 |
| 5 years (Oct 2020 – Sep 2025) | $188 | $182 |
| Since data start (Jul 2019 – Sep 2025) | $217 | $206 |
CNRVX Trailing Returns
Total returns to Sep 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +13.92% |
| 3 years (annualised) | +21.92% |
| 5 years (annualised) | +13.45% |
CNRVX Annual Returns
Calendar-year total returns of City National Rochdale U.s. Core Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Sep) | +12.47% |
| 2024 | +20.10% |
| 2023 | +23.10% |
| 2022 | −20.13% |
| 2021 | +29.40% |
| 2020 | +14.58% |
| 2019 (Jul–Dec) | +10.17% |
CNRVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −5.7% | −1.2% | +2.8% | +3.9% | +6.2% | −0.7% | +3.2% | +1.7% | +2.1% | — | — | — |
| 2024 | +2.1% | +4.5% | +1.2% | +3.6% | +4.9% | −3.2% | +1.1% | +1.9% | +1.3% | −2.8% | +5.8% | −1.5% |
| 2023 | +4.7% | −3.3% | +4.9% | +5.9% | −0.8% | +1.9% | −4.5% | −1.2% | +2.6% | +3.7% | +8.7% | −1.0% |
| 2022 | +2.4% | −3.5% | −7.4% | −7.6% | −0.5% | −8.4% | −9.2% | −4.3% | +9.4% | −5.2% | +6.1% | +8.4% |
| 2021 | +4.6% | +1.7% | −2.3% | +2.2% | +0.8% | +6.4% | −5.0% | +2.5% | +4.8% | +5.1% | −0.8% | +6.8% |
| 2020 | −13.0% | −7.5% | +1.1% | +1.1% | +5.1% | +9.3% | −3.0% | +7.3% | +6.6% | +3.3% | +8.5% | −2.5% |
| 2019 | — | — | — | — | — | — | +0.9% | +0.7% | +1.6% | +2.3% | +2.7% | +1.7% |
CNRVX Risk
Risk measures from monthly returns over Oct 2022 – Sep 2025.
- 3-year volatility (annualised): 12.82%
- 3-year Sharpe ratio: 1.36 (vs 4.5% risk-free rate)
- Best month: +8.69% (Nov 2023)
- Worst month: −5.68% (Jan 2025)
CNRVX Fund Flows
Monthly money in and out of City National Rochdale U.s. Core Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$15.8M
- 12-month gross sales (incl. reinvestments): $96.1M
- Sales ÷ redemptions: 0.86×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Sep 2025 | $3.6M | $8.3M | −$4.6M |
| Aug 2025 | $2.4M | $5.3M | −$2.8M |
| Jul 2025 | $2.4M | $8.2M | −$5.9M |
| Jun 2025 | $6.9M | $9.5M | −$2.6M |
| May 2025 | $4.0M | $12.0M | −$8.0M |
| Apr 2025 | $3.1M | $6.8M | −$3.8M |
| Mar 2025 | $15.2M | $8.5M | $6.7M |
| Feb 2025 | $6.3M | $13.6M | −$7.2M |
| Jan 2025 | $3.3M | $6.9M | −$3.6M |
| Dec 2024 | $2.6M | $7.6M | −$5.0M |
| Nov 2024 | $2.6M | $5.4M | −$2.7M |
| Oct 2024 | $43.6M | $19.8M | $23.8M |
CNRVX Assets Under Management
Net assets of City National Rochdale U.s. Core Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-09-30 | $381.91M |
| 2025-06-30 | $369.09M |
| 2025-03-31 | $351.33M |
| 2024-12-31 | $371.30M |
| 2024-09-30 | $412.30M |
| 2024-06-30 | $398.91M |
| 2024-03-31 | $391.45M |
| 2023-12-31 | $365.28M |
| 2023-09-30 | $364.30M |
| 2023-06-30 | $385.44M |
| 2023-03-31 | $369.72M |
| 2022-12-31 | $349.64M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.